Menu
GeneBe

LYST

lysosomal trafficking regulator, the group of WD repeat domain containing|BEACH domain containing |MicroRNA protein coding host genes

Basic information

Region (hg38): 1:235661040-235883724

Previous symbols: [ "CHS1" ]

Links

ENSG00000143669NCBI:1130OMIM:606897HGNC:1968Uniprot:Q99698AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Chediak-Higashi syndrome (Definitive), mode of inheritance: AR
  • Chediak-Higashi syndrome (Strong), mode of inheritance: AR
  • Chediak-Higashi syndrome (Strong), mode of inheritance: AR
  • Chediak-Higashi syndrome (Supportive), mode of inheritance: AR
  • attenuated Chédiak-Higashi syndrome (Supportive), mode of inheritance: AR
  • Chediak-Higashi syndrome (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Chediak-Higashi syndromeARAllergy/Immunology/Infectious; Hematologic; OncologicIndividuals can have infection susceptibility, and prophylaxis and early and aggressive treatment of infections can be beneficial; Surveillance for hematologic complications and malignancy is warranted; For the accelerated phase, chemoimmunotherapy then transition to continuation therapy can be beneficial; For bleeding, platelet transfusions and DDAVP may be beneficial to prevent and/or treat episodes; BMT/HSCT has been describedAllergy/Immunology/Infectious; Dermatologic; Hematologic; Neurologic; Oncologic13584476; 5908967; 5156632; 5064229; 711501; 2697195; 2070553; 2058369; 8030398; 8701696; 9215680; 10422800; 10527680; 11857544; 15790783; 20503323; 20301751; 21488161; 23521865; 24521565

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the LYST gene.

  • Chédiak-Higashi syndrome (2631 variants)
  • not provided (328 variants)
  • Inborn genetic diseases (163 variants)
  • not specified (114 variants)
  • Autoinflammatory syndrome (84 variants)
  • LYST-related condition (20 variants)
  • Chediak-Higashi syndrome, childhood type (3 variants)
  • Spastic ataxia (3 variants)
  • Seizure (3 variants)
  • Chediak-Higashi syndrome, adult type (2 variants)
  • Thrombocytopenia;Abnormal bleeding (1 variants)
  • Optic neuropathy (1 variants)
  • Susceptibility to severe COVID-19 (1 variants)
  • Abnormal bleeding;Thrombocytopenia (1 variants)
  • Recurrent infections (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the LYST gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
21
clinvar
628
clinvar
13
clinvar
662
missense
4
clinvar
1301
clinvar
25
clinvar
7
clinvar
1337
nonsense
40
clinvar
26
clinvar
2
clinvar
68
start loss
0
frameshift
33
clinvar
26
clinvar
1
clinvar
60
inframe indel
1
clinvar
23
clinvar
24
splice donor/acceptor (+/-2bp)
1
clinvar
20
clinvar
1
clinvar
22
splice region
37
74
3
114
non coding
41
clinvar
273
clinvar
121
clinvar
435
Total 74 77 1390 926 141

Highest pathogenic variant AF is 0.0000197

Variants in LYST

This is a list of pathogenic ClinVar variants found in the LYST region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-235661079-G-T Chédiak-Higashi syndrome Uncertain significance (Jan 13, 2018)296318
1-235661109-T-G Chédiak-Higashi syndrome Conflicting classifications of pathogenicity (Nov 01, 2022)296319
1-235661148-T-C Chédiak-Higashi syndrome Uncertain significance (Jan 13, 2018)296320
1-235661217-T-C Chédiak-Higashi syndrome Benign (Apr 27, 2017)873712
1-235661407-C-T Chédiak-Higashi syndrome Uncertain significance (Jan 12, 2018)873713
1-235661441-C-A Chédiak-Higashi syndrome Benign (Jan 13, 2018)873714
1-235661502-G-A Chédiak-Higashi syndrome Uncertain significance (Jan 13, 2018)296321
1-235661512-A-C Chédiak-Higashi syndrome Uncertain significance (Jan 12, 2018)296322
1-235661561-C-G Chédiak-Higashi syndrome Uncertain significance (Jan 13, 2018)296323
1-235661584-C-A Chédiak-Higashi syndrome Uncertain significance (Jan 13, 2018)296324
1-235661645-A-G Chédiak-Higashi syndrome Conflicting classifications of pathogenicity (Dec 01, 2022)296325
1-235661665-A-G Chédiak-Higashi syndrome Benign (Jan 12, 2018)296326
1-235661729-C-T Chédiak-Higashi syndrome Uncertain significance (Jan 13, 2018)296327
1-235661978-C-T Chédiak-Higashi syndrome Uncertain significance (Jan 12, 2018)874685
1-235662019-G-A Chédiak-Higashi syndrome Uncertain significance (Jan 12, 2018)874686
1-235662033-C-T Chédiak-Higashi syndrome Uncertain significance (Jan 12, 2018)296328
1-235662049-C-G Chédiak-Higashi syndrome Conflicting classifications of pathogenicity (Jan 01, 2023)296329
1-235662067-C-G Chédiak-Higashi syndrome Uncertain significance (Jan 13, 2018)296330
1-235662109-T-C Chédiak-Higashi syndrome Uncertain significance (Jan 13, 2018)296331
1-235662116-T-C Chédiak-Higashi syndrome Uncertain significance (Jan 12, 2018)296332
1-235662131-T-C Chédiak-Higashi syndrome Uncertain significance (Jan 13, 2018)875628
1-235662215-C-T Chédiak-Higashi syndrome Benign (Jan 12, 2018)296333
1-235662228-A-G Chédiak-Higashi syndrome Uncertain significance (Jan 13, 2018)875629
1-235662246-A-G Chédiak-Higashi syndrome Uncertain significance (Jan 13, 2018)296334
1-235662255-C-A Chédiak-Higashi syndrome Benign (Jan 13, 2018)296335

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
LYSTprotein_codingprotein_codingENST00000389794 51222600
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.01500.9851256580901257480.000358
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.4117581.93e+30.9100.00010125039
Missense in Polyphen592754.770.784349855
Synonymous-0.2327066981.010.00003757172
Loss of Function9.58441840.2390.00001042282

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0009980.000934
Ashkenazi Jewish0.00009930.0000992
East Asian0.0003290.000326
Finnish0.0005550.000554
European (Non-Finnish)0.0003440.000325
Middle Eastern0.0003290.000326
South Asian0.0002940.000294
Other0.0006550.000652

dbNSFP

Source: dbNSFP

Function
FUNCTION: May be required for sorting endosomal resident proteins into late multivesicular endosomes by a mechanism involving microtubules.;

Intolerance Scores

loftool
0.601
rvis_EVS
-3.04
rvis_percentile_EVS
0.5

Haploinsufficiency Scores

pHI
0.193
hipred
Y
hipred_score
0.530
ghis
0.545

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
gene_indispensability_pred
N
gene_indispensability_score
0.498

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Lyst
Phenotype
craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; neoplasm; pigmentation phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; vision/eye phenotype; immune system phenotype; renal/urinary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype;

Zebrafish Information Network

Gene name
lyst
Affected structure
liver
Phenotype tag
abnormal
Phenotype quality
fatty

Gene ontology

Biological process
lysosome organization;protein transport;leukocyte chemotaxis;melanosome organization;endosome to lysosome transport via multivesicular body sorting pathway;mast cell secretory granule organization;natural killer cell mediated cytotoxicity;defense response to bacterium;defense response to protozoan;pigmentation;defense response to virus
Cellular component
cytoplasm;microtubule cytoskeleton
Molecular function
protein binding